ICOM–ATU 2026 Orthomolecular Conference
The International Conference on Orthomolecular Medicine (ICOM-ATU 2026) takes place on October 27–29, at Aïn Témouchent Belhadj Bouchaib University in Algeria. Jointly organized by the University and the International Society for Orthomolecular Medicine (ISOM), the three-day conference is expected to welcome more than 250 participants from over 10 countries.
Under the theme Orthomolecular Approach for Health and Disease: From Cellular Function to Global Well-Being, ICOM-ATU 2026 explores how nutrition, cellular biochemistry and orthomolecular medicine can contribute to health promotion, disease prevention and the management of chronic disease. The conference places particular emphasis on translating advances in research into meaningful clinical applications.
Conference presentations and speakers:
Hybrid Orthomolecular Protocol for Cancer Disease
Dr. Ilyes Baghli
Orthomolecular Nutritional Strategies for Biocrisis Preparedness: Responding to Ebola, COVID-19 and Beyond
Dr. Atsuo Yanagisawa
Thiamine Pyrophosphate (TPP), the Key Coenzyme and Bioenergetic Therapies
Dr. Roberto Ortiz González
Oral Communication — The Universal Regulatory Role of Magnesium in Counteracting Metabolic Dysfunctions
Prof. Igor Bondarenko
The Role of Vitamin D in Maintaining Health and Treating Disease
Dr. William B. Grant
Origins and Evolution of Orthomolecular Medicine: The Canadian Experience and ISOM’s Contribution
Andrew Cuscianna
Glutathione and Alpha-Lipoic Acid: Beyond Antioxidant Therapy
Dr. Hiromichi Matsumura
Beyond Cholesterol: An Integrative Orthomolecular Perspective on Reversing Atherosclerotic Cardiovascular Disease
Dr. Richard Zhang Cheng
Oral Environment and Health: An Orthomolecular Medicine Perspective
Dr. Hiroki Morinaga
Alzheimer’s: Prevention is the Cure
Patrick Holford
The Microbiome: What We Know So Far
Dr. Sabine Hazan
Commercial Contaminants as Health Disruptors and Metabolic Correction for Recovery and Well-Being
Prof. Jorge R. Miranda-Massari
Nutripharmacological Approaches Using Neurotransmitters in Behavioral Disorders and Obesity
Dr. Efraín Olszewer
